about
Adverse Effects of Opioids on the Central Nervous Systems of Palliative Care PatientsTreating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.Physicians' experiences and perspectives regarding the use of continuous sedation until death for cancer patients in the context of psychological and existential suffering at the end of lifeIn-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugsMedication use during end-of-life care in a palliative care centre.Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life.Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium.European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus?Pain Management and Symptom-Oriented Drug Therapy in Palliative Care.Role of haloperidol in palliative medicine: an update.Assessment and management of delirium: a focus on hepatic encephalopathy.A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation.Clinical Assessment and Management of Delirium in the Palliative Care Setting[Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review].Akathisia and an unusual symptomatic treatment.A Protocol for the Control of Agitation in Palliative Care.A protocol for the acute control of agitation in palliative care: a preliminary report.Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study.Comparison of Haloperidol Alone and in Combination with Midazolam for the Treatment of Acute Agitation in an Inpatient Palliative Care Service.
P2860
Q29029910-73F8FEB3-C651-4295-ADD0-9E31C2265264Q33844380-6BE8A58E-DCE3-45A9-9559-B3EDA24543FAQ34807038-675906E1-EF35-4A4F-9EEF-F6E58C5B42BEQ36024396-83E2995C-46FA-4DCD-90F6-CC26E716B24BQ36123690-F28C7276-6A06-4304-A600-D65AADB6670AQ36329212-C7A5FC00-971F-4F9E-B6FE-4B3005B5E89AQ37293548-E7CAB73E-6C82-4110-A591-1991108E14FDQ37792645-954191BF-B0B3-4E45-A880-41BCBD6604FCQ37872595-B7DBA663-EDDC-409C-A8E8-D568821F0914Q37945595-9ED8D61D-DFF2-438C-813E-0EF31673AF52Q38049733-32FEFC58-BEDC-4904-8127-38BA9047B6FEQ39175922-947C078C-C70B-495B-8F1E-5597BDF736A4Q42005180-9E906C8E-D73D-401D-986C-46F01EE8B29AQ42182792-7EB0A4E2-CE59-4A58-9818-70E7D4275607Q43029299-1C2AAD59-7006-43F0-AC6C-16BEB55174F1Q46855525-9E2B5580-682A-4175-AA14-44F90FB422F7Q47370127-7FB7221F-D644-474A-BF69-31C376D44146Q48184005-F1746FB3-E0BA-4C43-BC30-6D71E7F39A2CQ50454201-E93139DD-F709-4F23-B39A-D1C2DFB43390Q51769363-D4CAB4E6-2C07-48B2-A45D-03525C32137B
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Haloperidol in palliative care
@ast
Haloperidol in palliative care
@en
Haloperidol in palliative care
@nl
type
label
Haloperidol in palliative care
@ast
Haloperidol in palliative care
@en
Haloperidol in palliative care
@nl
prefLabel
Haloperidol in palliative care
@ast
Haloperidol in palliative care
@en
Haloperidol in palliative care
@nl
P2860
P1433
P1476
Haloperidol in palliative care
@en
P2093
A D Macleod
Jane Vella-Brincat
P2860
P304
P356
10.1191/0269216304PM881OA
P407
P577
2004-04-01T00:00:00Z